<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Lipocalin-2 is a novel adipokine with connection to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we aimed to investigate the association of serum lipocalin-2 with <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism and other metabolic phenotype in a large-scale Chinese population </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We evaluated serum lipocalin-2 in a cross-sectional sample of 2519 Chinese aged from 50 to 82 year in a Shanghai downtown district by ELISA </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi>, insulin, <z:chebi fb="23" ids="18059">lipid</z:chebi> profile, inflammatory markers, and adipokines were also measured </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Serum lipocalin-2 was significantly higher in subjects with isolated impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, isolated <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo>, combined impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>/<z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> and newly-diagnosed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> than in those with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation </plain></SENT>
<SENT sid="5" pm="."><plain>Lipocalin-2 elevation was clearly associated with a higher risk for impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation (OR 1.30 for each 10 ng/ml increase in serum lipocalin-2, 95% CI 1.23-1.62, p = 0.009) after adjustment of age, gender, smoking, alcohol drinking, family history of <z:mp ids='MP_0002055'>diabetes</z:mp>, serum CRP, serum adiponectin, serum CXCL5, HOMA-IR, BMI, and waist/hip ratio </plain></SENT>
<SENT sid="6" pm="."><plain>The OR for participants with impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was 1.31 (95% CI 1.21-1.69, p &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Our findings suggest that elevated serum lipocalin-2 is closely and independently associated with impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>